dr. burtness on the use of biomarkers in metastatic hnscc
Published 5 years ago • 137 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:52
dr. burtness on promise of frontline pembrolizumab in metastatic hnscc
-
1:03
dr. burtness on the use of immunotherapy after chemoradiation in head and neck cancer
-
1:05
dr. burtness on combinations of immunotherapy in head and neck cancer
-
8:39
role of biomarkers in metastatic prostate cancer
-
5:19
predictive biomarkers in hnscc
-
1:43
dr. burtness on the 2 types of head and neck cancer
-
2:32
dr. cohen on biomarkers associated with response in patients with hnscc treated with afatinib
-
5:24
emerging biomarkers in metastatic gastric cancer
-
0:44
dr. burtness on the head and neck symposium design
-
1:34
dr. burtness on frontline immunotherapy in head and neck cancer
-
5:22
new therapies for hnscc
-
1:23
dr. burtness on the benefit of pembrolizumab in head and neck cancer
-
1:39
dr. bauml discusses biomarkers in head and neck cancer
-
2:07
dr. weiss on biomarkers in head and neck cancer
-
4:41
immunotherapy combinations for hnscc
-
1:43
dr. burtness on ongoing trials of immunotherapy in head and neck cancer
-
1:00
dr. cohen on biomarker testing in head and neck cancer
-
6:47
surgery for locally advanced hnscc
-
1:00
dr. burtness on immunotherapy and radioresistance in head and neck cancer